Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
68.78 CAD | -0.74% |
|
-0.53% | +1.69% |
Jun. 19 | Gildan Activewear Inc., Q1 2025 Earnings Call, Apr 29, 2025 | |
Apr. 30 | Toronto Stocks Retreat as March GDP Edges Higher; Gildan Activewear Up on 1Q Results, Outlook | DJ |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -1.9 | 10.53 | 12.02 | 9.88 | 12.03 | |||||
Return on Total Capital | -2.16 | 12.16 | 14.17 | 11.48 | 14.08 | |||||
Return On Equity % | -13.28 | 34.91 | 28.49 | 27.79 | 23.48 | |||||
Return on Common Equity | -13.28 | 34.91 | 28.49 | 27.79 | 23.48 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 9.74 | 28.41 | 29.58 | 27.54 | 30.69 | |||||
SG&A Margin | 13.74 | 10.75 | 10 | 10.34 | 9.42 | |||||
EBITDA Margin % | 1.6 | 21.72 | 22.74 | 20.41 | 24.91 | |||||
EBITA Margin % | -4.06 | 18.19 | 19.94 | 17.46 | 21.52 | |||||
EBIT Margin % | -4.78 | 17.75 | 19.51 | 17.2 | 21.27 | |||||
Income From Continuing Operations Margin % | -11.37 | 20.78 | 16.71 | 16.7 | 12.26 | |||||
Net Income Margin % | -11.37 | 20.78 | 16.71 | 16.7 | 12.26 | |||||
Net Avail. For Common Margin % | -11.37 | 20.78 | 16.71 | 16.7 | 12.26 | |||||
Normalized Net Income Margin | -4.52 | 10.51 | 11.48 | 9.19 | 11.3 | |||||
Levered Free Cash Flow Margin | 20.26 | 7.93 | -0.65 | 5.39 | 12.2 | |||||
Unlevered Free Cash Flow Margin | 21.32 | 8.31 | -0.1 | 6.51 | 13.83 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.64 | 0.95 | 0.99 | 0.92 | 0.9 | |||||
Fixed Assets Turnover | 1.96 | 2.87 | 2.85 | 2.61 | 2.59 | |||||
Receivables Turnover (Average Receivables) | 7.66 | 11.1 | 11.2 | 9.67 | 6.85 | |||||
Inventory Turnover (Average Inventory) | 2.01 | 2.79 | 2.28 | 2 | 2.06 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.29 | 3.12 | 2.69 | 2.33 | 2.22 | |||||
Quick Ratio | 2.21 | 1.28 | 0.7 | 0.76 | 0.83 | |||||
Operating Cash Flow to Current Liabilities | 1.15 | 1.33 | 0.64 | 0.75 | 0.6 | |||||
Days Sales Outstanding (Average Receivables) | 48.44 | 32.78 | 32.51 | 37.66 | 53.14 | |||||
Days Outstanding Inventory (Average Inventory) | 184.65 | 130.68 | 159.54 | 181.96 | 176.63 | |||||
Average Days Payable Outstanding | 80.86 | 59.09 | 49.03 | 58.79 | 57.4 | |||||
Cash Conversion Cycle (Average Days) | 152.23 | 104.37 | 143.01 | 160.83 | 172.36 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 71.91 | 38.1 | 55.83 | 55.97 | 114.3 | |||||
Total Debt / Total Capital | 41.83 | 27.59 | 35.83 | 35.88 | 53.34 | |||||
LT Debt/Equity | 68.42 | 36.15 | 45.7 | 39.28 | 91.69 | |||||
Long-Term Debt / Total Capital | 39.8 | 26.18 | 29.33 | 25.18 | 42.78 | |||||
Total Liabilities / Total Assets | 48.4 | 38.81 | 45.29 | 44.31 | 60.79 | |||||
EBIT / Interest Expense | -2.81 | 29.26 | 21.98 | 9.61 | 8.14 | |||||
EBITDA / Interest Expense | 1.38 | 36.6 | 26.14 | 11.64 | 9.7 | |||||
(EBITDA - Capex) / Interest Expense | -0.13 | 29.41 | 17.82 | 8.08 | 8 | |||||
Total Debt / EBITDA | 24.17 | 1.13 | 1.4 | 1.65 | 2.01 | |||||
Net Debt / EBITDA | 11.36 | 0.74 | 1.13 | 1.44 | 1.82 | |||||
Total Debt / (EBITDA - Capex) | -261.67 | 1.4 | 2.05 | 2.37 | 2.44 | |||||
Net Debt / (EBITDA - Capex) | -123.01 | 0.92 | 1.66 | 2.08 | 2.21 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -29.84 | 47.51 | 10.88 | -1.38 | 2.34 | |||||
Gross Profit, 1 Yr. Growth % | -73.93 | 329.58 | 15.45 | -8.28 | 14.45 | |||||
EBITDA, 1 Yr. Growth % | -93.79 | 1.89K | 16.1 | -11.6 | 24.25 | |||||
EBITA, 1 Yr. Growth % | -120.64 | -762.7 | 21.55 | -13.77 | 25.41 | |||||
EBIT, 1 Yr. Growth % | -125.43 | -648.84 | 21.9 | -13.2 | 25.82 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -186.71 | -369.52 | -10.81 | -1.47 | -24.87 | |||||
Net Income, 1 Yr. Growth % | -186.71 | -369.52 | -10.81 | -1.47 | -24.87 | |||||
Normalized Net Income, 1 Yr. Growth % | -142.99 | -443.51 | 21.16 | -21.18 | 24.99 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -189.76 | -369.3 | -4.56 | 3.41 | -18.81 | |||||
Accounts Receivable, 1 Yr. Growth % | -38.78 | 67.94 | -24.6 | 65.8 | 31.48 | |||||
Inventory, 1 Yr. Growth % | -30.8 | 6.37 | 58.32 | -11.13 | 1.94 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -10.51 | 12.68 | 10.73 | 5.27 | 1.02 | |||||
Total Assets, 1 Yr. Growth % | -5.92 | 3.83 | 9.68 | 2.17 | 5.7 | |||||
Tangible Book Value, 1 Yr. Growth % | -13.12 | 25.1 | 3.88 | 3.17 | -34.59 | |||||
Common Equity, 1 Yr. Growth % | -15.02 | 23.13 | -1.94 | 4 | -25.58 | |||||
Cash From Operations, 1 Yr. Growth % | 14.96 | 48.79 | -33.04 | 32.19 | -8.27 | |||||
Capital Expenditures, 1 Yr. Growth % | -60.62 | 151.54 | 87.61 | -14.99 | -28.51 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 119.18 | -42.3 | -108.85 | -937.61 | 128.75 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 107.91 | -42.55 | -101.29 | -8.09K | 115.25 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 46.32 | 10.06 | 10.22 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -17.47 | 1.73 | 27.89 | 4.57 | 0.46 | |||||
Gross Profit, 2 Yr. CAGR % | -51.06 | 5.89 | 122.7 | 2.96 | 2.28 | |||||
EBITDA, 2 Yr. CAGR % | -76.83 | 11.5 | 380.44 | 1.37 | 5.06 | |||||
EBITA, 2 Yr. CAGR % | -58.21 | 16.8 | 183.82 | 2.46 | 4.29 | |||||
EBIT, 2 Yr. CAGR % | -53.47 | 18.03 | 158.66 | 2.95 | 4.81 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -19.86 | 52.87 | 55.04 | -6.26 | -13.96 | |||||
Net Income, 2 Yr. CAGR % | -19.86 | 52.87 | 55.04 | -6.26 | -13.96 | |||||
Normalized Net Income, 2 Yr. CAGR % | -40.63 | 21.44 | 104.01 | -2.19 | -0.41 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -17.11 | 55.48 | 60.32 | -0.65 | -8.37 | |||||
Accounts Receivable, 2 Yr. CAGR % | -21.29 | 1.4 | 12.53 | 11.81 | 47.65 | |||||
Inventory, 2 Yr. CAGR % | -12 | -14.21 | 29.77 | 18.61 | -4.82 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.74 | 0.42 | 11.7 | 7.96 | 3.12 | |||||
Total Assets, 2 Yr. CAGR % | 0.27 | -1.17 | 6.71 | 5.86 | 3.92 | |||||
Tangible Book Value, 2 Yr. CAGR % | -10.12 | 4.25 | 14 | 3.53 | -17.85 | |||||
Common Equity, 2 Yr. CAGR % | -10.27 | 2.29 | 9.88 | 0.99 | -12.03 | |||||
Cash From Operations, 2 Yr. CAGR % | -12.21 | 30.78 | -0.19 | -5.92 | 10.12 | |||||
Capital Expenditures, 2 Yr. CAGR % | -31.39 | -0.47 | 117.24 | 26.29 | -22.04 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 13.78 | 12.47 | -77.02 | -15.2 | 340.26 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 13.88 | 9.3 | -91.26 | -8.9 | 1.22K | |||||
Dividend Per Share, 2 Yr. CAGR % | - | -8.84 | - | 26.9 | 10.14 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -10.36 | 0.16 | 4.69 | 17.28 | 3.82 | |||||
Gross Profit, 3 Yr. CAGR % | -37.77 | 0.99 | 8.98 | 65.75 | 6.53 | |||||
EBITDA, 3 Yr. CAGR % | -62.07 | 2.41 | 13.01 | 173.38 | 8.66 | |||||
EBITA, 3 Yr. CAGR % | -43.45 | 4.91 | 18.36 | 90.9 | 9.81 | |||||
EBIT, 3 Yr. CAGR % | -39.32 | 5.84 | 19.3 | 79.84 | 10.28 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -14.65 | 20.07 | 27.74 | 33.3 | -12.93 | |||||
Net Income, 3 Yr. CAGR % | -14.65 | 20.07 | 27.74 | 33.3 | -12.93 | |||||
Normalized Net Income, 3 Yr. CAGR % | -28.97 | 6.53 | 21.35 | 48.67 | 6.38 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -10.87 | 22.77 | 32.14 | 38.52 | -7.12 | |||||
Accounts Receivable, 3 Yr. CAGR % | -6.88 | 1.33 | -8.14 | 28.05 | 18.02 | |||||
Inventory, 3 Yr. CAGR % | -8.35 | -6.26 | 5.23 | 14.38 | 12.77 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -2.63 | 2.85 | 3.75 | 9.51 | 5.6 | |||||
Total Assets, 3 Yr. CAGR % | 0.45 | 1.44 | 2.32 | 5.18 | 5.8 | |||||
Tangible Book Value, 3 Yr. CAGR % | -9.29 | 0.35 | 4.13 | 10.27 | -11.17 | |||||
Common Equity, 3 Yr. CAGR % | -8.74 | -0.29 | 0.86 | 7.88 | -8.79 | |||||
Cash From Operations, 3 Yr. CAGR % | -12.21 | 4.67 | 4.63 | 9.61 | -6.71 | |||||
Capital Expenditures, 3 Yr. CAGR % | -18.02 | 5.79 | 22.94 | 58.9 | 4.47 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -1.05 | -9.26 | -51.26 | -24.56 | 18.5 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -0.22 | -9.34 | -74.85 | -21.03 | 21.72 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -0.57 | 6.73 | - | 21.08 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -5.06 | 2.48 | 3.33 | 1.9 | 2.98 | |||||
Gross Profit, 5 Yr. CAGR % | -22.43 | 2.9 | 3.65 | 1.77 | 6.27 | |||||
EBITDA, 5 Yr. CAGR % | -42.23 | 4.04 | 4.86 | 2 | 9.79 | |||||
EBITA, 5 Yr. CAGR % | -27.34 | 5.78 | 7.76 | 3.92 | 12.55 | |||||
EBIT, 5 Yr. CAGR % | -24.22 | 6.24 | 8.32 | 4.67 | 13.32 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -8.23 | 11.86 | 8.37 | 8.75 | 9.06 | |||||
Net Income, 5 Yr. CAGR % | -8.23 | 11.86 | 8.37 | 8.75 | 9.06 | |||||
Normalized Net Income, 5 Yr. CAGR % | -17.01 | 6.21 | 8.29 | 2.95 | 12.16 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.24 | 15.87 | 12.72 | 12.8 | 14.14 | |||||
Accounts Receivable, 5 Yr. CAGR % | -8.49 | 3.51 | 0.44 | 5.4 | 11.06 | |||||
Inventory, 5 Yr. CAGR % | -3.08 | -4.1 | 5.33 | 2.99 | 1.09 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -1.75 | 0.01 | 2.87 | 4.86 | 3.5 | |||||
Total Assets, 5 Yr. CAGR % | 1.28 | 0.96 | 2.91 | 3.19 | 2.96 | |||||
Tangible Book Value, 5 Yr. CAGR % | -8.55 | -3.2 | -0.61 | 1.61 | -5.29 | |||||
Common Equity, 5 Yr. CAGR % | -6.56 | -1.97 | -1.71 | 0.22 | -4.51 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.97 | 2.8 | -7.58 | 0.3 | 6.79 | |||||
Capital Expenditures, 5 Yr. CAGR % | -27.64 | -0.3 | 21.06 | 13.56 | 2.46 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | 9.2 | -44.81 | -11.08 | 16.85 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | 9.07 | -62.32 | -8.57 | 17.36 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 7.12 | 11.49 | 9.62 | 8.08 |
- Stock Market
- Equities
- GIL Stock
- Financials Gildan Activewear Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions